Cns Pharmaceuticals Inc

CNSP NASDAQ Santé & Biotech États-Unis US18978H1023
5.08 $
0.94 %

Cns Pharmaceuticals se spécialise dans le développement de traitement contre les cancers du cerveau, y compris les glioblastomes.

Performance & Momentum

6 Months 26.09 %
1 Year 57.62 %
3 Years 99.99 %
5 Years 100.00 %

Similar stocks to Cns Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Cns Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases